The potential cost-effectiveness of novel cord blood therapies in children with autism spectrum disorder is a research paper published in PLoS ONE (2023). On theSindex it has a DataRank of 0. It has been cited 1 time.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Marcus Foundation
Grant: Grant #2438
National Institutes for Health
Grant: F30 DC 019846
National Institutes of Health
Grant: 5F30DC019846-02
Economic Evaluation and Research Prioritization of Adult Hearing Screening in the US
FWCI
0.13
Citation Percentile
0.4%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals